The same AAV2-VEGF-Trap vector was assayed in combination with temozolomide (TMZ) or bevacizumab in a murine glioma model and synergistically decreased the microvascular density and enhanced tumor apoptosis [172]. This evidence concerns the gene VEGFA and neoplasm.